Your browser doesn't support javascript.
loading
Is elimination of HCV in 2030 realistic in Central Europe.
Flisiak, Robert; Zarebska-Michaluk, Dorota; Frankova, Sona; Grgurevic, Ivica; Hunyady, Bela; Jarcuska, Peter; Kupcinskas, Limas; Makara, Michael; Simonova, Marieta; Sperl, Jan; Tolmane, Ieva; Vince, Adriana.
Afiliação
  • Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
  • Zarebska-Michaluk D; Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland.
  • Frankova S; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Grgurevic I; Department of Gastroenterology, Hepatology and Clinical Nutrition, University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia.
  • Hunyady B; Department of Gastroenterology, First Department of Medicine, Somogy County Kaposi Mór Teaching Hospital, Kaposvár and University of Pécs, Clinical Center, Pécs, Hungary.
  • Jarcuska P; 2nd Department of Internal Medicine, Louis Pasteur University Hospital and Pavol Jozej Safárik University, Faculty of Medicine, Kosice, Slovakia.
  • Kupcinskas L; Institute for Digestive Research and Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Makara M; Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, Budapest, Hungary.
  • Simonova M; Department of Gastroenterology, HPB Surgery and Transplantology, Military Medical Academy, Sofia, Bulgaria.
  • Sperl J; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • Tolmane I; Latvian Center of Infectious Diseases, Riga East University Hospital, Hepatology Department, Faculty of Medicine, University of Latvia, Riga, Latvia.
  • Vince A; Department for Viral Hepatitis, University Hospital of Infectious Diseases, University of Zagreb School of Medicine, Zagreb, Croatia.
Liver Int ; 41 Suppl 1: 56-60, 2021 06.
Article em En | MEDLINE | ID: mdl-34155796
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / COVID-19 Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite C / COVID-19 Tipo de estudo: Diagnostic_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article